Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10201831rdf:typepubmed:Citationlld:pubmed
pubmed-article:10201831lifeskim:mentionsumls-concept:C0020962lld:lifeskim
pubmed-article:10201831lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:10201831lifeskim:mentionsumls-concept:C1528871lld:lifeskim
pubmed-article:10201831pubmed:issue5lld:pubmed
pubmed-article:10201831pubmed:dateCreated1999-6-4lld:pubmed
pubmed-article:10201831pubmed:abstractTextWe compared effects of alpha-galactosylceramide (alpha-GalCer) and its 3alpha- or 3beta-galactosylated derivatives on the proliferation of murine spleen cells. The 3alpha-galactosylated alpha-GalCer showed stronger proliferative response than the parental alpha-GalCer, but the 3beta-galactosylated alpha-GalCer possessed weaker activity than the alpha-GalCer. In addition, alpha-Gal-3-Cer did not show immunostimulatory activity.lld:pubmed
pubmed-article:10201831pubmed:languageenglld:pubmed
pubmed-article:10201831pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10201831pubmed:citationSubsetIMlld:pubmed
pubmed-article:10201831pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10201831pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10201831pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10201831pubmed:statusMEDLINElld:pubmed
pubmed-article:10201831pubmed:monthMarlld:pubmed
pubmed-article:10201831pubmed:issn0960-894Xlld:pubmed
pubmed-article:10201831pubmed:authorpubmed-author:IijimaHHlld:pubmed
pubmed-article:10201831pubmed:authorpubmed-author:MoritaMMlld:pubmed
pubmed-article:10201831pubmed:authorpubmed-author:SakaiTTlld:pubmed
pubmed-article:10201831pubmed:authorpubmed-author:YokoyamaTTlld:pubmed
pubmed-article:10201831pubmed:authorpubmed-author:MatsunagaNNlld:pubmed
pubmed-article:10201831pubmed:authorpubmed-author:AkimotoKKlld:pubmed
pubmed-article:10201831pubmed:authorpubmed-author:KoezukaYYlld:pubmed
pubmed-article:10201831pubmed:issnTypePrintlld:pubmed
pubmed-article:10201831pubmed:day8lld:pubmed
pubmed-article:10201831pubmed:volume9lld:pubmed
pubmed-article:10201831pubmed:ownerNLMlld:pubmed
pubmed-article:10201831pubmed:authorsCompleteYlld:pubmed
pubmed-article:10201831pubmed:pagination697-702lld:pubmed
pubmed-article:10201831pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10201831pubmed:meshHeadingpubmed-meshheading:10201831...lld:pubmed
pubmed-article:10201831pubmed:meshHeadingpubmed-meshheading:10201831...lld:pubmed
pubmed-article:10201831pubmed:meshHeadingpubmed-meshheading:10201831...lld:pubmed
pubmed-article:10201831pubmed:meshHeadingpubmed-meshheading:10201831...lld:pubmed
pubmed-article:10201831pubmed:meshHeadingpubmed-meshheading:10201831...lld:pubmed
pubmed-article:10201831pubmed:meshHeadingpubmed-meshheading:10201831...lld:pubmed
pubmed-article:10201831pubmed:meshHeadingpubmed-meshheading:10201831...lld:pubmed
pubmed-article:10201831pubmed:meshHeadingpubmed-meshheading:10201831...lld:pubmed
pubmed-article:10201831pubmed:meshHeadingpubmed-meshheading:10201831...lld:pubmed
pubmed-article:10201831pubmed:meshHeadingpubmed-meshheading:10201831...lld:pubmed
pubmed-article:10201831pubmed:year1999lld:pubmed
pubmed-article:10201831pubmed:articleTitleEffects of 3alpha- and 3beta-galactosylated alpha-galactosylceramides on the immune system.lld:pubmed
pubmed-article:10201831pubmed:affiliationPharmaceutical Research Laboratory, Kirin Brewery Co., Ltd., Gunma, Japan.lld:pubmed
pubmed-article:10201831pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10201831pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:10201831lld:chembl